Congress Proposes Bill to Give Veterans Access to Psychedelic and Experimental Medical Treatments
Also known as: Expanding Veterans’ Access to Emerging Treatments Act
Legislative Progress
Impacts
Key Points
Milestones
What Happens Next
Projected impacts based on AI analysis
Related News
4 articles
Bipartisan Congressional Lawmakers File Bill Directing VA To Study Psychedelics As Alternative Therapies For Veterans
Reps. Jack Bergman and Lou Correa filed the 'Expanding Veterans’ Access to Emerging Treatments Act' to direct the VA to carry out clinical trials on innovative treatments, including psychedelics like psilocybin and MDMA, and develop compassionate access protocols for veterans with PTSD.
Clearmind's MEAI added to U.S. veterans therapy bill
The Expanding Veterans' Access to Emerging Treatments Act of 2026 (H.R. 7091) directs the VA to establish an investigational research and extended access program for innovative therapies including psilocybin, MDMA, and MEAI to address unmet medical needs in veterans.

Veterans’ 2026 Priorities Put Health Care, Suicide Prevention to Congress
As Congress returns for 2026, veterans' advocates are pressing lawmakers to prioritize access to quality healthcare and suicide prevention. The agenda includes scaling innovative care and evidence-based therapies beyond VA facilities to reach veterans in crisis.